Active, not recruitingNCT02104310

A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas

Studying PLA2G6-associated neurodegeneration

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mayo Clinic
Principal Investigator
Nadia N Laack, MD, MD
Mayo Clinic
Intervention
Fluorine-18-L-dihydroxyphenylalanine(drug)
Enrollment
25 target
Eligibility
7 years · All sexes
Timeline
20142031

Study locations (1)

Collaborators

Brains Together for the Cure

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02104310 on ClinicalTrials.gov

Other trials for PLA2G6-associated neurodegeneration

Additional recruiting or active studies for the same condition.

See all trials for PLA2G6-associated neurodegeneration

← Back to all trials